Cangen Biotechnologies


About Cangen Team Pipelines Strategic Partners Investor Relations News Releases Locations Contact Us


	Cangen Biotechnologies is developing the next generation of early cancer diagnostics and designing chemo-sensitivity methods for the selection of optimal cancer therapies.

Cangen Biotechnologies, Inc.
300 East Lombard Street
Suite 1600
Baltimore, Maryland 21202

Mail to:
Suite 830

Temporary address until new facilities are completed at the Johns Hopkins BioPark

Phone: (443) 703-2800